Do Prestige’s Higher Margins and New Dramamine Formats Reveal a Sharper Brand Strategy for PBH?

Simply Wall St.

May 25

In May 2026, Prestige Consumer Healthcare reported fourth-quarter sales of US$281.62 million versus US$296.52 million a year earlier, while net income rose to US$53.93 million and annual guidance ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2638585413"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2638585413\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2638585413?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","is_english":true,"pubTime":"2026-05-25 08:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2638585413","market":"nz","top_or_hot":-1,"title":"Do Prestige’s Higher Margins and New Dramamine Formats Reveal a Sharper Brand Strategy for PBH?","media":"Simply Wall St.","content":"<div>\n<p>In May 2026, Prestige Consumer Healthcare reported fourth-quarter sales of US$281.62 million versus US$296.52 million a year earlier, while net income rose to US$53.93 million and annual guidance ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pbh/prestige-consumer-healthcare/news/do-prestiges-higher-margins-and-new-dramamine-formats-reveal\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Do Prestige’s Higher Margins and New Dramamine Formats Reveal a Sharper Brand Strategy for PBH?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDo Prestige’s Higher Margins and New Dramamine Formats Reveal a Sharper Brand Strategy for PBH?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-25 08:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pbh/prestige-consumer-healthcare/news/do-prestiges-higher-margins-and-new-dramamine-formats-reveal><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In May 2026, Prestige Consumer Healthcare reported fourth-quarter sales of US$281.62 million versus US$296.52 million a year earlier, while net income rose to US$53.93 million and annual guidance ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pbh/prestige-consumer-healthcare/news/do-prestiges-higher-margins-and-new-dramamine-formats-reveal\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XBI","symbol_name":"SPDR S&P Biotech ETF","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pbh/prestige-consumer-healthcare/news/do-prestiges-higher-margins-and-new-dramamine-formats-reveal","article_id":"2638585413","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pbh/prestige-consumer-healthcare/news/do-prestiges-higher-margins-and-new-dramamine-formats-reveal","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2638585413","pubTimestamp":1779668452,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In May 2026, Prestige Consumer Healthcare reported fourth-quarter sales of US$281.62 million versus US$296.52 million a year earlier, while net income rose to US$53.93 million and annual guidance outlined expected fiscal 2027 revenue of US$1.10–US$1.12 billion and GAAP diluted EPS of US$4.31–US$4.40.\nA few days later, its Dramamine brand introduced new travel-friendly Less Drowsy Powder stick packs and Nausea Chewables, broadening its nausea relief options across major US retailers and...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"XBI":"SPDR S&P Biotech ETF","BK4007":"制药","BK4588":"碎股","BK4585":"ETF&股票定投概念","PBH":"普雷斯蒂奇","LABU":"三倍做多标普生物-Direxion","BK4581":"高盛持仓","XLV":"健康照护类股ETF-SPDR"},"translate_title":"Prestige更高的利润率和新的晕海明形式是否揭示了PBH更清晰的品牌战略？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":0.6,"XLV":0.9,"PBH":1.5,"XBI":0.6},"content_text":"In May 2026, Prestige Consumer Healthcare reported fourth-quarter sales of US$281.62 million versus US$296.52 million a year earlier, while net income rose to US$53.93 million and annual guidance outlined expected fiscal 2027 revenue of US$1.10–US$1.12 billion and GAAP diluted EPS of US$4.31–US$4.40. A few days later, its Dramamine brand introduced new travel-friendly Less Drowsy Powder stick packs and Nausea Chewables, broadening its nausea relief options across major US retailers and Amazon. We’ll now explore how the new Dramamine formats and Prestige’s higher quarterly profitability influence the company’s existing investment narrative. Outshine the giants: these 13 early-stage AI stocks could fund your retirement.AdvertisementPrestige Consumer Healthcare Investment Narrative RecapTo own Prestige Consumer Healthcare, you need to believe its portfolio of everyday health brands can keep generating solid cash flow despite supply chain issues and retail volatility. The latest quarter showed lower sales but higher earnings, suggesting cost discipline, while the new Dramamine formats are incremental rather than a clear fix for the near term risks around Clear Eyes supply recovery and retailer ordering patterns. The most relevant recent announcement here is Prestige’s fiscal 2027 guidance for US$1.10–US$1.12 billion in revenue and GAAP diluted EPS of US$4.31–US$4.40. Set just days before the Dramamine launches, this outlook gives a reference point for how much impact, if any, these product extensions might have on reported results and on the company’s ability to manage margin pressures and retail demand swings. But while new products and guidance support the story, investors should also be aware of the risk that ongoing supply chain volatility in eye care could... Read the full narrative on Prestige Consumer Healthcare (it's free!)Prestige Consumer Healthcare's narrative projects $1.2 billion revenue and $243.2 million earnings by 2029. This requires 4.2% yearly revenue growth and about a $56.7 million earnings increase from $186.5 million today.Uncover how Prestige Consumer Healthcare's forecasts yield a $78.50 fair value, a 64% upside to its current price.Exploring Other PerspectivesPBH 1-Year Stock Price Chart Before this news, the most optimistic analysts were assuming revenues near US$1.4 billion and earnings of about US$222.9 million by 2029, which paints a far more upbeat picture than the consensus view. As you weigh the new Dramamine launches against that kind of growth story and the execution risks around eye care capacity, it is worth considering how much your own expectations line up with these more aggressive forecasts or sit closer to the baseline.Explore another fair value estimate on Prestige Consumer Healthcare - why the stock might be worth as much as 64% more than the current price!The Verdict Is YoursDon't just follow the ticker - dig into the data and build a conviction that's truly your own.A great starting point for your Prestige Consumer Healthcare research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.Our free Prestige Consumer Healthcare research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Prestige Consumer Healthcare's overall financial health at a glance.Looking For Alternative Opportunities?Every day counts. These free picks are already gaining attention. See them before the crowd does:This technology could replace computers: discover 28 stocks that are working to make quantum computing a reality.We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}